180 related articles for article (PubMed ID: 18698350)
1. Global eradication of lymphatic filariasis: the value of chronic disease control in parasite elimination programmes.
Michael E; Malecela MN; Zervos M; Kazura JW
PLoS One; 2008 Aug; 3(8):e2936. PubMed ID: 18698350
[TBL] [Abstract][Full Text] [Related]
2. Information technology in morbidity management of human lymphatic filariasis-A promising tool in global programme for elimination of lymphatic filariasis.
Devi RR; Raju V
J Vector Borne Dis; 2018; 55(1):20-25. PubMed ID: 29916444
[TBL] [Abstract][Full Text] [Related]
3. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
[TBL] [Abstract][Full Text] [Related]
4. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
[TBL] [Abstract][Full Text] [Related]
5. Current practices in the management of lymphatic filariasis.
Bockarie MJ; Taylor MJ; Gyapong JO
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):595-605. PubMed ID: 19485799
[TBL] [Abstract][Full Text] [Related]
6. Success against lymphatic filariasis.
Cao W; Van der Ploeg CP; Ren Z; Habbema JD
World Health Forum; 1997; 18(1):17-20. PubMed ID: 9233057
[TBL] [Abstract][Full Text] [Related]
7. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
Ramaiah KD; Das PK; Vanamail P; Pani SP
Trop Med Int Health; 2003 Dec; 8(12):1082-92. PubMed ID: 14641843
[TBL] [Abstract][Full Text] [Related]
8. Mathematical modelling and the control of lymphatic filariasis.
Michael E; Malecela-Lazaro MN; Simonsen PE; Pedersen EM; Barker G; Kumar A; Kazura JW
Lancet Infect Dis; 2004 Apr; 4(4):223-34. PubMed ID: 15050941
[TBL] [Abstract][Full Text] [Related]
9. Mathematical models and lymphatic filariasis control: endpoints and optimal interventions.
Michael E; Malecela-Lazaro MN; Kabali C; Snow LC; Kazura JW
Trends Parasitol; 2006 May; 22(5):226-33. PubMed ID: 16564745
[TBL] [Abstract][Full Text] [Related]
10. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
[TBL] [Abstract][Full Text] [Related]
11. Current status and future prospects of the Global Lymphatic Filariasis Programme.
Molyneux DH; Taylor MJ
Curr Opin Infect Dis; 2001 Apr; 14(2):155-9. PubMed ID: 11979126
[TBL] [Abstract][Full Text] [Related]
12. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
[TBL] [Abstract][Full Text] [Related]
13. Potential factors influencing lymphatic filariasis transmission in "hotspot" and "control" areas in Ghana: the importance of vectors.
Pi-Bansa S; Osei JHN; Frempong KK; Elhassan E; Akuoko OK; Agyemang D; Ahorlu C; Appawu MA; Koudou BG; Wilson MD; de Souza DK; Dadzie SK; Utzinger J; Boakye DA
Infect Dis Poverty; 2019 Feb; 8(1):9. PubMed ID: 30717788
[TBL] [Abstract][Full Text] [Related]
14. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.
Bockarie MJ; Alexander ND; Hyun P; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW
Lancet; 1998 Jan; 351(9097):162-8. PubMed ID: 9449870
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets.
Jones C; Ngasalla B; Derua YA; Tarimo D; Malecela MN
Int J Infect Dis; 2017 Aug; 61():38-43. PubMed ID: 28527817
[TBL] [Abstract][Full Text] [Related]
16. Mapping is a prerequisite for elimination of filariasis and effective targeting of filarial 'hot spots'.
Chand G; Kaushal LS; Choudhari NK; Singh N
Pathog Glob Health; 2016; 110(4-5):157-63. PubMed ID: 27413817
[TBL] [Abstract][Full Text] [Related]
17. Strategies and tools for the control/elimination of lymphatic filariasis.
Ottesen EA; Duke BO; Karam M; Behbehani K
Bull World Health Organ; 1997; 75(6):491-503. PubMed ID: 9509621
[TBL] [Abstract][Full Text] [Related]
18. Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis.
Gambhir M; Michael E
PLoS One; 2008 Aug; 3(8):e2874. PubMed ID: 18716676
[TBL] [Abstract][Full Text] [Related]
19. [Technical measures of filariasis elimination in Tengzhou City].
Ma XW; Zhang XQ; Xu YL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(4):232-4. PubMed ID: 12568031
[TBL] [Abstract][Full Text] [Related]
20. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.
Stolk WA; Swaminathan S; van Oortmarssen GJ; Das PK; Habbema JD
J Infect Dis; 2003 Nov; 188(9):1371-81. PubMed ID: 14593597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
